View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Hyper-CVAD (Cyclophosphamide 300 / Vincristine 2 / Doxorubicin 50 / Dexamethasone 40) / Rituximab 375 / Imatinib 400, ALL/NHL, Ph/BCR-ABL+, intensification, month 7,19
Protocol-ID: 2113 V1.0 (Mini), Hyper-CVAD (CYCL300/VNCR2/DOXO50/DEXA40)/RITU375/IMAT400, ALL/NHL, Ph/BCR-ABL+, intensification, month 7.19Indication(s)
- Acute Lymphoblastic Leukaemia (Ph/BCR-ABL+, B-ALL, T-ALL); ICD-10 C91.0-
- NHL, B-Cell Type, Burkitt's Lymphoma; ICD-10 C83.7
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.07.2022